Events
Translational Medicine: Essential Ingredient in the Personalized Medicine Formula
Tuesday, October 27, 2009
12:00 – 1:30 pm EDT
To access the archived webcast, please click here.
To view the materials for this event, please click here.
Translational medicine, which calls for development and access to better information as a means of practicing better medicine, is an essential ingredient in the rapid movement toward personalized medicine. Now is the time to develop a strategy for becoming an active participant in this arena. In the real-world context of recent leading-edge translational medicine initiatives, this program will explore essential organizational, operational and legal considerations involved in the development and implementation of a strategic plan, including the following topics:
- The design of innovative organizational structures
- The creation of massive data and tissue repositories, and the information technology infrastructure to support them
- The identification of potential partners and structuring of collaborations
Speakers
Bernadette Broccolo, Partner & Co-Chair, Personalized Medicine Group, McDermott Will & Emery LLP
Keith Strier, Principal, Health Sciences & Government, Deloitte LLP
Dietrich Stephan, Ph.D., President and CEO, IGNITE Institute for Individualized Health
This program is the first webcast in a three-part series, Personalized Medicine: Thriving in a Rapidly Changing World, conducted by McDermott Will & Emery and Deloitte LLP.
Upcoming Webcasts
Targeted Therapies: Navigating the Business Challenges of Personalized Medicine and ROI – Tuesday, December 1, 2009
Customizing Care: The Future of Personalized Medicine – Wednesday, January 27, 2010
